EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Systemic Arterial Hypertension, Inflammation

In brief

The study aims to evaluate the effect of the royal jelly and propolis on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.

Key facts

Study ID

NCT07596966

Run by

Universidade Federal Fluminense

People needed

48

Starts

2025-10-15

Expected to finish

2027-12-10

Last updated by the study team

2026-05-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of stage 1 and 2 hypertension
• Regular treatment for more than 6 months
• There have been no changes in medication doses over the last three months.

You may not qualify if…

• Autoimmune and infectious diseases, diabetes
• Chronic kidney disease, liver disease, cancer and AIDS
• Pregnant women
• Use of catabolic drugs or antibiotics
• Use of antioxidant vitamin supplements, prebiotics, probiotics, symbiotic
• Habitual intake of royal jelly and propolis

Where it is running

• Denise Mafra — Niterói, Rio de Janeiro, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.